Utama › Sindrom Mielodisplastik › Ohio › Columbus
Kajian klinikal Sindrom Mielodisplastik di Columbus, OH
14 kajian untuk Sindrom Mielodisplastik sedang mencari peserta di lokasi dalam dan sekitar Columbus (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Ohio State University Comprehensive Cancer Center, Columbus
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Mengambil pesertaFasa 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Mengambil pesertaFasa 1/2
- The Ohio State University, Columbus
Collection of Tissue Samples for Cancer Research
Mengambil pesertaKajian pemerhatian
- Ohio State University, Columbus
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Mengambil pesertaFasa 1
- Ohio State University, The James Comprehensive Cancer, Columbus
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Mengambil pesertaFasa 3
- Ohio State University Comprehensive Cancer Center, Columbus
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Mengambil pesertaFasa 1/2
- Nationwide Children's Hospital, Columbus
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
Mengambil pesertaFasa 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Mengambil pesertaFasa 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Mengambil pesertaFasa 1
- Ohio State University Medical Center, Columbus
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Mengambil pesertaFasa 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Columbus
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Mengambil pesertaFasa 1
- The Ohio State University Wexner Medical Center - James Cancer Hosp, Columbus
HPC Offered for PRESERVE Expansion
Mengambil pesertaKajian pemerhatian
- The Ohio State University Medical Center, Columbus
Kajian Sindrom Mielodisplastik di bandar lain
- Houston, TX43 kajian
- Baldwin Park, CA26 kajian
- New York City, NY21 kajian
- Seattle, WA21 kajian
- Washington, DC20 kajian
- Boston, MA19 kajian
- Tampa, FL19 kajian
- Miami, FL17 kajian
- Durham, NC14 kajian
- Chicago, IL13 kajian
- Atlanta, GA13 kajian
- St. Louis, MO13 kajian
Kajian lain di Columbus
- Kanser Paru-paru Bukan Sel Kecil56 kajian
- Kanser Payudara39 kajian
- Kanser Ovari39 kajian
- Kanser (semua jenis)38 kajian
- Kanser Paru-paru37 kajian
- Leukemia Mieloid Akut35 kajian
- Leukemia Limfositik Kronik28 kajian
- Kanser Metastatik27 kajian
- Kanser Endometrium25 kajian
- Kanser Kolorektal24 kajian
- Kanser Prostat24 kajian
- Mieloma Pelbagai24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.